Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2006 | 03-2006 | 03-2005 | 03-2004 | 03-2003 | |
| Sales | 0 | 297,740 | 78,540 | 0 | 68,960 |
| Cost of Goods | N/A | 128,690 | 35,090 | N/A | 24,580 |
| Gross Profit | N/A | 169,050 | 43,440 | 56,360 | 44,380 |
| Operating Expenses | 0 | 154,540 | 36,250 | 11,720 | 26,840 |
| Operating Income | N/A | 15,200 | 7,290 | -11,720 | 18,120 |
| Interest Expense | 0 | 0 | 2,030 | 0 | 270 |
| Other Income | 0 | -7,910 | -20 | 0 | 0 |
| Pre-tax Income | 0 | 7,290 | 5,240 | -11,720 | 17,850 |
| Income Tax | N/A | 1,610 | 250 | N/A | 3,730 |
| Net Income Continuous | N/A | 5,680 | 11,075 | 61,155 | 44,555 |
| Net Income | $N/A | $5,670 | $5,020 | $61,155 | $13,980 |
| EPS Basic Total Ops | N/A | 0.19 | 0.38 | 2.12 | 1.55 |
| EPS Basic Continuous Ops | N/A | 0.19 | 0.38 | 2.12 | 1.55 |
| EPS Diluted Total Ops | N/A | N/A | 0.37 | 2.06 | 1.52 |
| EPS Diluted Continuous Ops | N/A | N/A | 0.37 | 2.06 | 1.52 |
| EBITDA(a) | $N/A | $40,480 | $7,290 | $-11,720 | $26,520 |